CD4 and Thrombocytopenia: Thrombocytopenia (platelet< 150,000/μL) was found in 11.1%(n = 40) of the study subjects, the prevalence was 8.5%(18/212) and 14.8%(22/149) for female and male patients respectively (Table 4), (p = 0.089); 2%(1/51) and 10.1%(8/79) for AZT and non AZT based HAART patients, respectively, (p = 0.579) (data not shown).There was no difference between the prevalence of thrombocytopenia in relation to immunologic stage (CD4 category) (Table 6), WHO clinical stages (Table 7) and ART status (Table 5).